Tarun Garg
Overview
Explore the profile of Tarun Garg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1387
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Goyal A, Garg T, Rath G, Gupta U, Gupta P
Mol Pharm
. 2015 Oct;
12(11):3839-50.
PMID: 26436948
The foremost objective of the present research study was to develop and evaluate the potential of rifampicin (RIF) and isoniazid (INH) loaded spray dried nanoembedded microparticles against experimental tuberculosis (TB)....
12.
Garg T, Goyal A, Rath G, Murthy R
Pharm Dev Technol
. 2015 Sep;
21(8):951-960.
PMID: 26334961
Currently, one-third of the world's population is infected with tuberculosis (TB) mainly spread by inhalation of the tubercle bacilli, Mycobacterium tuberculosis. Patient non-compliance is the major reason for failure of...
13.
Singh J, Garg T, Rath G, Goyal A
Drug Deliv
. 2015 Aug;
23(5):1676-98.
PMID: 26289212
From the early sixteenth and seventeenth centuries to the present day of life, tuberculosis (TB) still is a global health threat with some new emergence of resistance. This type of...
14.
Singh B, Garg T, Goyal A, Rath G
Artif Cells Nanomed Biotechnol
. 2015 Jul;
44(6):1498-507.
PMID: 26134924
The objective of the current investigation was to develop a novel biocomposite polymeric nanofiber for sublingual delivery of nicorandil in an attempt to reduce mucosal ulceration and to improve drug...
15.
Chaudhary C, Garg T
Crit Rev Ther Drug Carrier Syst
. 2015 Jun;
32(4):277-321.
PMID: 26080925
A scaffold is comprised of the polymeric central components, which are used to deliver cells, drugs, and genes into the body. Wounds, which lead to a loss of integrity of...
16.
Gupta P, Garg T, Tanmay M, Arora S
Crit Rev Ther Drug Carrier Syst
. 2015 Jun;
32(3):247-75.
PMID: 26080810
Permeability glycoprotein (P-gp), a multispecific drug transporter belonging to the multidrug resistance (MDR) gene subfamily, is mainly responsible for efflux of diffused intracellular drugs, resulting in poor drug bioavailability. P-gp...
17.
Garg T, Rath G, Murthy R, Gupta U, Vatsala P, Goyal A
Curr Pharm Des
. 2015 Jun;
21(22):3076-89.
PMID: 26027577
Tuberculosis (TB) is an airborne communicable disease, mainly caused by aerobic, non-motile, rodshaped, weakly gram-positive, acid-fast tubercular bacillus Mycobacterium tuberculosis (MTb). Mycobacterium has worsened the problem in humans by acquiring...
18.
Garg T, Rath G, Goyal A
Crit Rev Ther Drug Carrier Syst
. 2015 May;
32(2):89-147.
PMID: 25955882
In this paper, we provide an overview an extensive range of colloidal drug delivery systems with special focus on vesicular and particulates systems that are being used in research or...
19.
Garg T, Rath G, Goyal A
Artif Cells Nanomed Biotechnol
. 2015 Apr;
44(6):1374-82.
PMID: 25919064
Psoriasis is a chronic disorder with erythematous scaly patches, which typically affects the exposed surfaces of the body and scalp. Various factors such as bacterial infection, genetic and environmental factors,...
20.
Garg T, Bhandari S, Rath G, Goyal A
J Drug Target
. 2015 Apr;
23(10):865-87.
PMID: 25835469
Brain tumor is one of the most challenging diseases to treat. The major obstacle in the specific drug delivery to brain is blood-brain barrier (BBB). Mostly available anti-cancer drugs are...